Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 228.70
-14.65 (-6.02%)
At close: Jun 1, 2026
Chandan Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,764 | 2,301 | 1,766 | 1,369 | 1,196 |
Other Revenue | 42.79 | 12.48 | 0.91 | - | - |
| 2,807 | 2,314 | 1,767 | 1,369 | 1,196 | |
Revenue Growth (YoY) | 21.31% | 30.95% | 29.07% | 14.49% | 37.17% |
Cost of Revenue | 1,337 | 1,105 | 826.12 | 666.72 | 634.11 |
Gross Profit | 1,470 | 1,208 | 940.69 | 702.18 | 561.53 |
Selling, General & Admin | 441.97 | 461.65 | 412.81 | 294.16 | 219.87 |
Other Operating Expenses | 459.48 | 320.86 | 263.02 | 314.22 | 319.12 |
Operating Expenses | 999.24 | 849.95 | 709.87 | 629.27 | 558.59 |
Operating Income | 470.64 | 358.36 | 230.82 | 72.91 | 2.94 |
Interest Expense | -58.82 | -40.53 | -24.81 | -18.02 | -15.99 |
Interest & Investment Income | - | 7.3 | 10.64 | 0.8 | 1.46 |
Other Non Operating Income (Expenses) | - | -4.48 | -2.05 | -5.58 | 0.99 |
EBT Excluding Unusual Items | 411.82 | 320.65 | 214.61 | 50.11 | -10.6 |
Other Unusual Items | -29.15 | - | - | - | - |
Pretax Income | 382.67 | 320.65 | 214.61 | 50.11 | -10.6 |
Income Tax Expense | 97.13 | 85.49 | 51.05 | 14.25 | 0.32 |
Earnings From Continuing Operations | 285.54 | 235.16 | 163.56 | 35.86 | -10.93 |
Minority Interest in Earnings | -14.96 | -13.44 | -0.79 | -2.18 | -0.16 |
Net Income | 270.57 | 221.71 | 162.77 | 33.68 | -11.09 |
Net Income to Common | 270.57 | 221.71 | 162.77 | 33.68 | -11.09 |
Net Income Growth | 22.04% | 36.21% | 383.29% | - | - |
Shares Outstanding (Basic) | 24 | 21 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 25 | 21 | 20 | 20 | 20 |
Shares Change (YoY) | 22.23% | 2.86% | - | - | - |
EPS (Basic) | 11.07 | 10.78 | 8.14 | 1.68 | -0.55 |
EPS (Diluted) | 10.76 | 10.78 | 8.14 | 1.68 | -0.55 |
EPS Growth | -0.16% | 32.42% | 384.44% | - | - |
Free Cash Flow | -263.81 | -677.58 | -184.25 | -7.82 | -5.42 |
Free Cash Flow Per Share | -10.49 | -32.94 | -9.21 | -0.39 | -0.27 |
Dividend Per Share | - | - | 1.500 | 1.000 | 0.500 |
Dividend Growth | - | - | 50.00% | 100.00% | - |
Gross Margin | 52.37% | 52.23% | 53.24% | 51.30% | 46.97% |
Operating Margin | 16.77% | 15.49% | 13.06% | 5.33% | 0.25% |
Profit Margin | 9.64% | 9.58% | 9.21% | 2.46% | -0.93% |
Free Cash Flow Margin | -9.40% | -29.29% | -10.43% | -0.57% | -0.45% |
EBITDA | 568.44 | 425.81 | 264.86 | 93.8 | 22.54 |
EBITDA Margin | 20.25% | 18.40% | 14.99% | 6.85% | 1.88% |
D&A For EBITDA | 97.8 | 67.45 | 34.04 | 20.9 | 19.61 |
EBIT | 470.64 | 358.36 | 230.82 | 72.91 | 2.94 |
EBIT Margin | 16.77% | 15.49% | 13.06% | 5.33% | 0.25% |
Effective Tax Rate | 25.38% | 26.66% | 23.79% | 28.43% | - |
Revenue as Reported | 2,807 | 2,322 | 1,778 | 1,370 | 1,199 |